Myeloid-derived suppressor cells coming of age

被引:1281
|
作者
Veglia, Filippo [1 ]
Perego, Michela [1 ]
Gabrilovich, Dmitry [1 ]
机构
[1] Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA
基金
美国国家卫生研究院;
关键词
REGULATORY T-CELLS; CLINICAL-SIGNIFICANCE; TUMOR MICROENVIRONMENT; DISEASE PROGRESSION; DENDRITIC CELLS; STRESS-RESPONSE; SYNOVIAL-FLUID; POOR-PROGNOSIS; GM-CSF; CANCER;
D O I
10.1038/s41590-017-0022-x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population of cells generated during a large array of pathologic conditions ranging from cancer to obesity. These cells represent a pathologic state of activation of monocytes and relatively immature neutrophils. MDSCs are characterized by a distinct set of genomic and biochemical features, and can, on the basis of recent findings, be distinguished by specific surface molecules. The salient feature of these cells is their ability to inhibit T cell function and thus contribute to the pathogenesis of various diseases. In this Review, we discuss the origin and nature of these cells; their distinctive features; and their biological roles in cancer, infectious diseases, autoimmunity, obesity and pregnancy.
引用
收藏
页码:108 / 119
页数:12
相关论文
共 50 条
  • [41] Targeting Myeloid-Derived Suppressor Cells in Cancer
    Anani, Waseem
    Shurin, Michael R.
    [J]. TUMOR IMMUNE MICROENVIRONMENT IN CANCER PROGRESSION AND CANCER THERAPY, 2017, 1036 : 105 - 128
  • [42] In Brief: Myeloid-derived suppressor cells in cancer
    Solito, S.
    Pinton, L.
    Mandruzzato, S.
    [J]. JOURNAL OF PATHOLOGY, 2017, 242 (01): : 7 - 9
  • [43] Myeloid-Derived Suppressor Cells (MDSCs) in Haematology
    Bizymi, Nikoleta
    Papadaki, Helen A.
    [J]. JOURNAL OF CLINICAL MEDICINE, 2022, 11 (01)
  • [44] Induction of myelodysplasia by myeloid-derived suppressor cells
    Chen, Xianghong
    Eksioglu, Erika A.
    Zhou, Junmin
    Zhang, Ling
    Djeu, Julie
    Fortenbery, Nicole
    Epling-Burnette, Pearlie
    Van Bijnen, Sandra
    Dolstra, Harry
    Cannon, John
    Youn, Je-in
    Donatelli, Sarah S.
    Qin, Dahui
    De Witte, Theo
    Tao, Jianguo
    Wang, Huaquan
    Cheng, Pingyan
    Gabrilovich, Dmitry I.
    List, Alan
    Wei, Sheng
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2013, 123 (11): : 4595 - 4611
  • [45] Myeloid-Derived Suppressor Cells in Solid Tumors
    Ma, Tianmiao
    Renz, Bernhard W.
    Ilmer, Matthias
    Koch, Dominik
    Yang, Yuhui
    Werner, Jens
    Bazhin, Alexandr V.
    [J]. CELLS, 2022, 11 (02)
  • [46] MYELOID-DERIVED SUPPRESSOR CELLS IN LUNG TRANSPLANTATION
    Heigl, Tobias
    Singh, Anurag
    Saez-Gimenez, Berta
    Kaes, Janne
    vanHerck, Anke
    Sacreas, Annelore
    Beeckmans, Hanne
    Vanstapel, Arno
    Verleden, Stijn
    vanRaemdonck, Drik
    Verleden, Geert
    Vanaudenaerde, Bart
    Hartl, Dominik
    Vos, Robin
    [J]. TRANSPLANT INTERNATIONAL, 2019, 32 : 108 - 108
  • [47] Tumor Microenvironment and Myeloid-Derived Suppressor Cells
    Umansky, Viktor
    Sevko, Alexandra
    [J]. CANCER MICROENVIRONMENT, 2013, 6 (02) : 169 - 177
  • [48] Myeloid-derived suppressor cells in immunity and autoimmunity
    Yang, Hui
    Bi, Yujing
    Han, Fei
    Lu, Yun
    Wang, Jian
    Zhang, Zhengguo
    Liu, Guangwei
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2015, 11 (08) : 911 - 919
  • [49] Radioprotective properties of myeloid-derived suppressor cells
    Cullinan, Darren R.
    Cripe, James C.
    Hawkins, William G.
    Goedegebuure, S. Peter
    [J]. TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S923 - S925
  • [50] Myeloid-derived suppressor cells and pulmonary hypertension
    Zhang, Hui
    Li, Qi-Wei
    Li, Yuan-Yuan
    Tang, Xue
    Gu, Ling
    Liu, Han-Min
    [J]. FRONTIERS IN IMMUNOLOGY, 2023, 14